Literature DB >> 10862227

Managing hypertension in patients with renal disease and diabetes.

R Grad, S Hanley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862227      PMCID: PMC1231332     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  23 in total

Review 1.  Preservation of renal function: the spectrum of effects by calcium-channel blockers.

Authors:  N Tarif; G L Bakris
Journal:  Nephrol Dial Transplant       Date:  1997-11       Impact factor: 5.992

Review 2.  Failure to comply: a therapeutic dilemma and the bane of clinical trials.

Authors:  M Gibaldi
Journal:  J Clin Pharmacol       Date:  1996-08       Impact factor: 3.126

3.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

4.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

5.  Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.

Authors:  A Guasch; M Parham; C F Zayas; O Campbell; C Nzerue; E Macon
Journal:  J Am Soc Nephrol       Date:  1997-05       Impact factor: 10.121

Review 6.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

7.  Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.

Authors:  G L Bakris; J B Copley; N Vicknair; R Sadler; S Leurgans
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

8.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

9.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.